PLUS THERAPEUTICS, INC. (PSTV) › Operating IncomePLUS THERAPEUTICS, INC. (PSTV) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2009: -$21.55M2010: -$25.32M2011: -$29.41M2012: -$28.42M2013: -$30.68M2014: -$32.44M2015: -$15.29M2016: -$19.71M2017: -$20.68M2018: -$8.76M2019: -$3.66M2020: -$9.58M2021: -$12.49M2022: -$19.71M2023: -$13.32M2024: -$14.70M2025: -$15.30M-$15.30M2009Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$15.30M-4.1%2024-$14.70M-10.3%2023-$13.32M+32.4%2022-$19.71M-57.8%2021-$12.49M-30.3%2020-$9.58M-162.1%2019-$3.66M+58.3%2018-$8.76M+57.6%2017-$20.68M-5.0%2016-$19.71M-28.9%2015-$15.29M+52.9%2014-$32.44M-5.7%2013-$30.68M-8.0%2012-$28.42M+3.4%2011-$29.41M-16.1%2010-$25.32M-17.5%2009-$21.55M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share